Achilles Therapeutics’ $175.5 Million Initial Public Offering

Latham & Watkins LLP represented the underwriters in the offering while Goodwin Procter LLP advised Achilles Therapeutics plc. Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here